26.08.2013 Views

Endogenous allergen assessments - Europabio

Endogenous allergen assessments - Europabio

Endogenous allergen assessments - Europabio

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Design, relevance and limitations of<br />

current endogenous <strong>allergen</strong><br />

<strong>assessments</strong><br />

Scott McClain, Ph.D.<br />

Syngenta Crop Protection, LLC<br />

Research Triangle Park, NC USA


Design of studies is based, in part, on available<br />

technology<br />

2<br />

-Serologydetection<br />

of <strong>allergen</strong>s<br />

with patient IgE or<br />

animal IgG antibody<br />

-Protein Separation-<br />

Visualize individual<br />

proteins with<br />

stains/serum IgE using<br />

electrophoresis as a<br />

foundation<br />

-Analytical-<br />

Mass spectrometry<br />

is the newest<br />

multiplexing,<br />

quantitative<br />

methodology


IgE, ug/ml<br />

Question: Are <strong>Endogenous</strong> Allergens in Biotech Crops<br />

Increased Relative to Their non-GM Counterparts?<br />

● Has been applied to GM soybean because soybean is considered a<br />

major <strong>allergen</strong>ic food<br />

● Traditionally, the technology available was based on serology:<br />

3<br />

- Use soybean allergic sera as a detection reagent for <strong>allergen</strong>-IgE<br />

binding - measure <strong>allergen</strong> content.<br />

• Total anti-soybean IgE binding ELISA – measures IgE that is specific<br />

to “all” of the <strong>allergen</strong>s a person may be responsive to; quantitatively,<br />

if validated.<br />

• Gel Electrophoresis and Western blotting; can observe binding to<br />

multiple, individual <strong>allergen</strong>s.<br />

Total<br />

IgE<br />

To discriminate individual <strong>allergen</strong>s by ELISA with<br />

serum, individual ELISAs with protein standards<br />

would need to be validated – for soybean this<br />

would minimally be > 8 separate assays*.<br />

Allergen #1<br />

* - University of Nebraska, FARRP <strong>allergen</strong>online.org


Protein Separation and Western Blotting<br />

● Western blotting (WB), and in particular 2-dimensional WB, is of<br />

interest for observing individual proteins<br />

4<br />

- A qualitative observation of the proteins binding serum IgE antibody.<br />

• Although “spots” can be optically measured in general, the<br />

technique is considered semi-quantitative since there are<br />

no standard curves assessed for individual <strong>allergen</strong>s (in<br />

most cases).<br />

- Also perceived as beneficial for observing “new” <strong>allergen</strong>s that<br />

may be present in GM variety…<br />

this is improbable given that new varieties are assessed<br />

prior to market release and exposure. There is also no<br />

premise for new proteins, much less new <strong>allergen</strong>s being<br />

created by introduction of GM trait(s).


2-D Electrophoresis and Western Blotting<br />

Total protein stain shown – Red circle indicates observable soybean proteins by Western<br />

5<br />

Gel Electrophoretic pattern<br />

Taken from Batista et al., 2007. Int Arch Allergy Immunol 2007;144:29–38<br />

IgE reactivity to all of the<br />

possible soybean<br />

<strong>allergen</strong>s is very limited<br />

in a single serum


Considerations for Serology Based Studies<br />

6<br />

Primary Limitation – limited availability of well-characterized sera.<br />

- Variability in IgE binding across one or more proteins among different<br />

patients.<br />

• Not all patients have IgE against a given <strong>allergen</strong> of the same<br />

affinity – thus, quantitative determinations are limited.<br />

- Soybean has many <strong>allergen</strong>s, so thoroughly characterizing the exact<br />

same set of proteins with good reproducibility from one study to the<br />

next is not possible since sera will vary temporally among patients.<br />

- Virtually impossible to have same set of patient sera form one study to<br />

next


Liquid Chromatography MS/MS for Protein<br />

Identification<br />

7<br />

1. Proteins are digested into peptides<br />

2. Peptides are separated to reduce complexity<br />

3. Peptides are “weighed” and sequenced by mass spectrometry<br />

4. Peptide sequence provides protein identification through bioinformatics<br />

S.E. Stevenson, Houston N., and Thelen J. 2010. Regul. Toxicol. Pharmacol.<br />

58, 3, S36-41.


AQUA® Peptide Analysis by MS to Quantify Proteins<br />

Two different<br />

isotopes to label<br />

amino acids<br />

These labeled<br />

(heavier) peptides<br />

can then act as<br />

peptide<br />

Standards<br />

Isotope labeled<br />

Native peptide<br />

AQUA peptide<br />

8<br />

H 2N<br />

H 2N<br />

HO<br />

C<br />

NH<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH<br />

C O<br />

NH<br />

Arginine (R) – 174.2<br />

13 C6H 14 15 N4O 2 – 184.2<br />

1 2<br />

H 2N<br />

HO<br />

NH 2<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH<br />

C O<br />

Lysine (K) – 146.19<br />

13 C6H 14 15 N2O 2 – 154.19<br />

LSAEFGSLR – 978.51 VSDDEFNNYK – 1229.52<br />

LSAEFGSLR – 988.51 VSDDEFNNYK – 1237.52


Aqua® Peptides and Quantifying; How does it work?<br />

9<br />

Seed <strong>allergen</strong> peptide (previously identified)<br />

signal<br />

Mix label<br />

with seed<br />

prep<br />

mass<br />

Labeled peptide standard<br />

+<br />

mass spectrometry can distinguish them<br />

+<br />

+<br />

Known amount of<br />

standard added<br />

Ratio gives quantity


Relevance of the Study Design for <strong>Endogenous</strong><br />

Allergen Content<br />

● Premise:<br />

10<br />

- <strong>Endogenous</strong> <strong>allergen</strong>s could, by some unknown mechanism, be<br />

influenced to express at a higher level in GM-traited soybean crops<br />

compared with non-GM<br />

- Soybean – although soybean has many <strong>allergen</strong>s, including<br />

abundant seed storage proteins, the threshold exposure to individual<br />

<strong>allergen</strong>s is not known.<br />

• Therefore, at this point in time, there is no knowledge of how<br />

many µg or mg of an <strong>allergen</strong> is significant from an allergy safety<br />

perspective –<br />

• this in turn limits the study design - a single comparison of GM<br />

versus non-GM control is not useful<br />

- The only relevant study that can be designed is to survey several<br />

non-GM references so there is context to the study in terms of the<br />

natural range of expression for one or more <strong>allergen</strong>s.


µg <strong>allergen</strong> protein/mg total protein<br />

Example – Observing Allergens in the Context of<br />

a Population of Non-GM Varieties (References)<br />

11<br />

120<br />

100<br />

80<br />

60<br />

40<br />

The difference is small<br />

relative to the variability<br />

in the references<br />

GlyG1<br />

GlyG2<br />

Allergen<br />

Test<br />

Control<br />

upper TI<br />

lower TI<br />

Many references can be used to<br />

show the probable range of<br />

expression for a population<br />

The differences between the GM<br />

“test” and its non-GM” control can<br />

then be assessed against the natural<br />

variability in <strong>allergen</strong> expression<br />

Conclusion – in this case, both<br />

<strong>allergen</strong>s show small differences for<br />

the GM variety that are not<br />

biologically relevant


Allergen Context: Understanding Natural Variability<br />

12<br />

Many non-GM reference samples help establish<br />

the concentration range for a new protein (i.e.,<br />

<strong>allergen</strong>) that has clinical implications; particularly<br />

when employing quantitative approaches<br />

Why is this important ?<br />

ug of <strong>allergen</strong> per mg protein<br />

If a protein is being characterized<br />

for the first time, it is critical to<br />

validate the population for its<br />

“normal” content<br />

In the future – the quantity of an<br />

<strong>allergen</strong> could potentially be<br />

correlated to threshold exposure<br />

levels to understand allergy<br />

impact


Soybeans<br />

13<br />

Glycine max<br />

Yes, it’s an<br />

<strong>allergen</strong>ic food<br />

But,<br />

We don’t know how much or<br />

how little causes allergy for<br />

any one of the many protein<br />

<strong>allergen</strong>s<br />

And,<br />

We don’t have evidence that<br />

GM varieties would be<br />

expected to differ in their<br />

<strong>allergen</strong> content<br />

For now,<br />

We can assess GM and<br />

non-GM, but not in<br />

isolation<br />

Small differences are<br />

unlikely to be relevant to<br />

allergy risk – Therefore,<br />

we need to understand<br />

small differences as best<br />

as we can<br />

We cannot predict endogenous<br />

allergy risk relative to a<br />

measured amount of protein…<br />

So, any assessment has to<br />

include a population of<br />

references to understand the<br />

natural variability for any single<br />

<strong>allergen</strong>


<strong>Endogenous</strong> Allergen Approaches<br />

● Question: Are <strong>Endogenous</strong> Allergens in Biotech Crops<br />

Increased Relative to Their non-GM Counterparts?<br />

● Question implies that the target protein(s) can be quantitatively<br />

measured with relevance to allergy risk<br />

14<br />

- ILSI/HESI protein <strong>allergen</strong>icity tech committee has<br />

supported work to use quantitative approaches to provide<br />

measures of soybean <strong>allergen</strong>s<br />

● Methods may include qualitative or quantitative<br />

approaches<br />

● Methods should be:<br />

• Sensitive<br />

• Specific<br />

• Reproducible


Relevance of the data – Can this data be<br />

interpreted for allergy risk?<br />

● Can we measure <strong>allergen</strong>s?<br />

15<br />

- Yes, ability is increasing all the time and with increasing sensitivity<br />

● What is the relevance to the population in terms of their risk for allergy?<br />

- Most <strong>allergen</strong>s still require further study to characterize their<br />

sensitization potential and the amount that causes clinical allergy<br />

- There is no existing hypothesis for a change to endogenous allergy<br />

risk based on GM varieties<br />

● So, even though we have the ability to measure <strong>allergen</strong> content the<br />

question remains – have we added value to the <strong>allergen</strong>icity<br />

assessment?


Contributing EuropaBio Member Companies<br />

● Bayer CropScience<br />

● BASF<br />

● Dow AgroSciences<br />

● Dupont Pioneer<br />

● Monsanto<br />

● Syngenta<br />

16


Questions and Discussion<br />

● Thank your for your attention<br />

17

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!